Verapamil-sustained release–based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: An INternational VErapamil SR-Trandolapril (INVEST) substudy
Sripal Bangalore, Franz H. Messerli, Jerome D. Cohen, Peter H. Bacher, Peter Sleight, Giuseppe Mancia, Peter Kowey, Qian Zhou, Annette Champion, Carl J. PepineVolume:
156
Année:
2008
Langue:
english
Pages:
248
DOI:
10.1016/j.ahj.2008.02.023
Fichier:
PDF, 174 KB
english, 2008